Dominic Costa, MBA, Ms Raqa, Ms, Cscp
About Dominic Costa, MBA, Ms Raqa, Ms, Cscp
Dominic Costa is the Director, Strategic Product Leader, Biologics Strategy & Business Excellence at Bristol Myers Squibb, with extensive experience in supply chain and product strategy roles at Merck.
Current Role at Bristol Myers Squibb
Dominic Costa is currently serving as Director, Strategic Product Leader for Biologics Strategy & Business Excellence at Bristol Myers Squibb in Princeton, New Jersey. In this role, he is responsible for overseeing the strategic direction and business excellence initiatives for the company's biologics products.
Previous Roles at Bristol Myers Squibb
Prior to his current role, Dominic Costa worked as a Life-Cycle Leader for Integrated Product Strategy in Biologics Immuno-Oncology at Bristol Myers Squibb from 2020 to 2023. During his three years in this position, he managed the life-cycle of immuno-oncology products, ensuring seamless integration and strategic planning.
Tenure at Merck
Dominic Costa has an extensive career at Merck, where he held multiple roles from 1999 to 2019. His roles ranged from Lead Laboratory Supervisor to Associate Director positions in both Supply Chain Management and Value Chain Management. He contributed significantly to the supply chain and regulatory affairs, providing strategic insights and management across various operational areas.
Educational Background
Dominic Costa holds multiple advanced degrees: an MBA from La Salle University (2008-2010), an MS in Regulatory Affairs & Quality Assurance from Temple University School of Pharmacy (2000-2002), and an MS in Environmental Health from Temple University College of Engineering (1997-1999). Additionally, he earned a BA in Physical Geography from East Stroudsburg University of Pennsylvania (1988-1993).
Professional Certifications and Specializations
Dominic Costa is a Certified Supply Chain Professional (CSCP) through APICS. He specializes in end-to-end asset life-cycle management, manufacturing supply strategy, value-chain delivery, business continuity, and has a deep understanding of FDA and regulatory compliance. His expertise also extends to Environmental, Sustainability, and Governance (ESG) programs.